- Home
- KLRS vs WBX Comparison
KLRS vs WBX Comparison
Compare KLRS & WBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLRS
- WBX
- Stock Information
- Founded
- KLRS 2019
- WBX 2015
- Country
- KLRS United States
- WBX Spain
- Employees
- KLRS N/A
- WBX N/A
- Industry
- KLRS Biotechnology: Biological Products (No Diagnostic Substances)
- WBX Industrial Specialties
- Sector
- KLRS Health Care
- WBX Consumer Discretionary
- Exchange
- KLRS Nasdaq
- WBX Nasdaq
- Market Cap
- KLRS 129.0M
- WBX 104.7M
- IPO Year
- KLRS N/A
- WBX N/A
- Fundamental
- Price
- KLRS $2.69
- WBX $4.83
- Analyst Decision
- KLRS Buy
- WBX Buy
- Analyst Count
- KLRS 1
- WBX 4
- Target Price
- KLRS N/A
- WBX $11.00
- AVG Volume (30 Days)
- KLRS 57.0K
- WBX 20.8K
- Earning Date
- KLRS 08-15-2025
- WBX 07-31-2025
- Dividend Yield
- KLRS N/A
- WBX N/A
- EPS Growth
- KLRS N/A
- WBX N/A
- EPS
- KLRS N/A
- WBX N/A
- Revenue
- KLRS N/A
- WBX $173,788,608.00
- Revenue This Year
- KLRS N/A
- WBX N/A
- Revenue Next Year
- KLRS N/A
- WBX $36.47
- P/E Ratio
- KLRS N/A
- WBX N/A
- Revenue Growth
- KLRS N/A
- WBX N/A
- 52 Week Low
- KLRS $2.28
- WBX $4.60
- 52 Week High
- KLRS $24.15
- WBX $32.80
- Technical
- Relative Strength Index (RSI)
- KLRS N/A
- WBX 52.82
- Support Level
- KLRS N/A
- WBX $5.90
- Resistance Level
- KLRS N/A
- WBX $6.60
- Average True Range (ATR)
- KLRS 0.00
- WBX 0.31
- MACD
- KLRS 0.00
- WBX -0.32
- Stochastic Oscillator
- KLRS 0.00
- WBX 4.24
About KLRS Kalaris Therapeutics Inc. Common Stock
Kalaris Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing therapeutics. Kalaris is developing TH103, a novel, clinical stage anti-vascular endothelial growth factor (VEGF) drug, engineered to potentially provide longer lasting and increased anti-VEGF activity in patients with exudative and neovascular retinal diseases. TH103 is a fully humanized recombinant fusion protein, functioning as a decoy receptor (a VEGF trap), leveraging salient molecular properties of the human body native, highest affinity VEGF receptor 1.
About WBX Wallbox N.V.
Wallbox NV is a smart electric vehicle charging and energy management company. It creates a smart charging system combining technology design that manages the communication between the user, vehicle, grid, building, and charger. The company designs, manufactures, and distributes faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments; Europe, Middle East and Asia (EMEA), its key revenue-generating segment, North America, and Asia-Pacific.